Breaks Categories: Stock Spotlights

TuesdayJan 04, 2022 2:28 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23…

Continue Reading

ThursdayDec 30, 2021 1:04 pm

CBDNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Selected as Official Water Supplier of Summer 2022 Highlight Event

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race. The three-day Canadian E-Fest is slated to take place between June 30 to July 2, 2022, and will welcome the ABB FIA Formula E…

Continue Reading

MondayDec 27, 2021 1:56 pm

CBDNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results

RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful data insights and is on a mission to transform patient care using big data and AI to reshape the understanding and uses of plant-based medicines. The company’s devices and data are being used by a rapidly growing number of participants in plant-based clinical trials around the world, including clinical research into the relationship between medical cannabis consumption and cancer treatment, which is in the very early stages. “Two key constraints that have limited the viability of cannabis studies within an oncological setting are the highly variable nature of the…

Continue Reading

ThursdayDec 23, 2021 1:05 pm

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Building World-Class House of Brands

Flora Growth Corp. (NASDAQ: FLGC) recently signed a licensing agreement with Tonino Lamborghini that marked Flora Growth’s entry into the cannabis beverages market. Under the terms of the partnership, FLGC will produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia. The product line, which will be produced in Florida for initial sale in U.S. states where cannabidiol (“CBD”) ingestibles are legal, will contain CBD and other premium cannabinoids, including cannabigerol (“CBG”). Tonino Lamborghini is a luxury brand operating in the high-end designer products, hotel, beverage and real estate segments. “We are excited to partner with such a…

Continue Reading

ThursdayDec 23, 2021 12:35 pm

CBDNewsBreaks – Marijuana Company of America Inc. (MCOA) Expanding Reach into New Regions, Leveraging Partnerships to Facilitate Growth

Marijuana Company of America (OTC: MCOA) has taken steps to extend its reach into new regions, including Latin America, and to leverage current strategic partnerships with several companies and its wholly owned subsidiaries to facilitate growth in an industry that continues to expand despite recent setbacks. Much like other industries around the world, the marijuana market was significantly impacted by the COVID-19 pandemic. The global cannabis market, which was valued at $22.1 billion in 2020, is expected to grow at a CAGR of 13.9% during the 2021 to 2026 forecast period. Companies that MCOA has partnered with include Cannabis Global…

Continue Reading

TuesdayDec 21, 2021 2:52 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study…

Continue Reading

FridayDec 17, 2021 2:49 pm

CBDNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focused on Florida Ahead of ‘Massive Medical Marijuana Boom’

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis sector operator, is off to a strong start in building its high-quality flower resource for product inventory at dispensaries throughout Florida. The company has been working to launch growing operations at its Apopka, Florida-based cultivation location, adding 19,200 square feet of production expected to deliver $30 million in annual revenues. The pods were approved by the state health department’s Office of Medical Marijuana Use (“OMMU”) with licensing granted just before Halloween, with five already in use for plant growth at that time with the remainder fast-tracked for output.…

Continue Reading

TuesdayDec 14, 2021 2:18 pm

CBDNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Performance Reflects Ability to Execute on Diversification Strategy

Marijuana Company of America (OTC: MCOA) is a diversified holding company that is looking to grow its business and further establish itself in the legalized cannabis THC, hemp and cannabidiol (“CBD”) industries. MCOA recently achieved the highest quarterly revenue in its history and expects to drive continued growth across the entire business. “As part of the financial results for three months ended Sept. 30, 2021 (‘Q3 2021’), the company reported $442,178 in revenue, up from $53,195 in revenue reported in Q3 2020. This represented a 731% year-on-year increase. In addition, the company’s gross profits grew by 297%, from $16,025 reported…

Continue Reading

MondayDec 13, 2021 1:17 pm

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Looking to Further Increase Share in Global Cannabis, Wellness Markets

Flora Growth Corp. (NASDAQ: FLGC), a company guided by the mission to build a connected, design-led collective of plant-based wellness and lifestyle brands that provide customers with a one-of-a-kind experience, recently announced it had closed the acquisition of Vessel Brand Inc., an industry leader in cannabis consumer technology. “This marks the addition of an exceptional brand builder with a proven track record of not only launching successful cannabis-related brands but also capturing market share in the rapidly-expanding United States cannabis landscape,” reads a recent article. “When making the announcement, Luis Merchan, the president and CEO of Flora Growth, noted, ‘With…

Continue Reading

MondayDec 13, 2021 12:54 pm

CBDNewsBreaks – RYAH Group Inc. (CSE: RYAH) Unearthing Breakthrough Discoveries That Will Reshape Understanding of Plant-Based Medicines

RYAH Group (CSE: RYAH) is a leading data technology company in plant-based medicine committed to providing valuable insight and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company is working to unearth breakthrough discoveries that will reshape the understanding of plant-based medicines.” In the blog post, for instance, RYAH provided an overview of the United Kingdom’s legal cannabis market, observing that “market analysts continue to place high hopes on the potential of the U.K. market. Yet, in its current form, there remains significant room for…

Continue Reading